Ontario Teachers Pension Plan Board Halozyme Therapeutics, Inc. Transaction History

Ontario Teachers Pension Plan Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$37.81 - $52.4 $52,593 - $72,888	-1,391 Reduced 4.37%	30,405 $1.59 Million
Q1 2024 May 10, 2024	SELL	$33.68 - $41.95 $85,884 - $106,972	-2,550 Reduced 7.42%	31,796 $1.29 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $662,468 - $837,032	19,882 Added 137.46%	34,346 $1.27 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $469,276 - $566,710	-12,871 Reduced 47.09%	14,464 $552,000
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $827,703 - $1.06 Million	27,335 New	27,335 $985,000
Q3 2019 Nov 08, 2019	SELL	$15.2 - $17.69 $500,976 - $583,044	-32,959 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$14.75 - $17.26 $486,145 - $568,872	32,959 New	32,959 $566,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.